"Hypopigmentation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
| Descriptor ID |
D017496
|
| MeSH Number(s) |
C17.800.621.440
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypopigmentation".
Below are MeSH descriptors whose meaning is more specific than "Hypopigmentation".
This graph shows the total number of publications written about "Hypopigmentation" by people in this website by year, and whether "Hypopigmentation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypopigmentation" by people in Profiles.
-
Pearson TF, Harris JE. Expanding the White Armor of Vitiligo. J Invest Dermatol. 2024 01; 144(1):5-7.
-
Ren H, Akabane AL, Kelleher K, Halverstam C, Hicks M, Schachter JR, Silverman R, Chachkin S, Sherman-Bergman S, Harris JE, Kuohung V. Vitiligo induced by dupilumab treatment: A case series. J Eur Acad Dermatol Venereol. 2023 11; 37(11):2259-2261.
-
Garza-Mayers AC, Paquette GM, Harris JE, Wiss K. Narrowband ultraviolet B phototherapy in pediatric vitiligo: A retrospective study. J Am Acad Dermatol. 2023 07; 89(1):135-136.
-
Paquette GM, Sherman S, Akabane A, Harris JE. Adolescent extra-truncal progressive macular hypomelanosis. Pediatr Dermatol. 2023 Jul-Aug; 40(4):702-705.
-
Pandya AG, Harris JE, Lebwohl M, Hamzavi IH, Butler K, Kuo FI, Wei S, Rosmarin D. Addition of Narrow-Band UVB Phototherapy to?Ruxolitinib Cream in Patients With Vitiligo. J Invest Dermatol. 2022 12; 142(12):3352-3355.e4.
-
Essien KI, Katz EL, Strassner JP, Harris JE. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo. J Invest Dermatol. 2022 12; 142(12):3158-3166.e7.
-
Rodrigues M, Pandya AG, Hamzavi I, Ezzedine K, Bekkenk MW, Harris JE. Treatment recommendations for patients with vitiligo during COVID-19. Australas J Dermatol. 2021 08; 62(3):e481-e482.
-
Frisoli ML, Harris JE. Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine. J Invest Dermatol. 2018 12; 138(12):2505-2506.
-
Fukuda K, Harris JE. Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo. J Am Acad Dermatol. 2018 01; 78(1):e15-e16.
-
Harris JE. Chemical-Induced Vitiligo. Dermatol Clin. 2017 Apr; 35(2):151-161.